Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of gemcitabine given by fixed dose rate intravenous
infusion in patients with pretreated metastatic colorectal cancer.